Main Session
Sep
30
LBA 01 - Late Breaking Abstracts
LBA 08 - Comprehensive Patient Reported Outcomes (PROs) from NRG LU005: A Randomized Trial Of Chemoradiation (CRT) +/- Atezolizumab In Limited-Stage Small Cell Lung Cancer (LS-SCLC)
Presenter(s)
Benjamin Movsas, MD, FASTRO - Henry Ford Cancer Institute, Detroit, Michigan